SCHEMBL931637

SCHEMBL931637

COC(=O)C1CCN(C(=O)OC(C)(C)C)C2=C(CC(C)C=C2C)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 8/20 0.34
KMT2A Q03164 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KDM1A O60341 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
PTPN6 P29350 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
EED O75530 1/20 0.31
RBBP4 Q09028 1/20 0.31
SUZ12 Q15022 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL949516 0.90 MAPT (0.37) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL931636 0.83 PTPN2 (0.33) STSKMT2APDE4APDE4BPDE4C
SCHEMBL947156 0.81 ALDH1A1 (0.40) KMT2AALDH1A1KDM4EMAPT
SCHEMBL18039817 0.74 PDE4B (0.46) STSPDE4APDE4BPDE4CPDE4D
SCHEMBL949514 0.73 MAPT (0.37) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL108497 0.71 LMNA (0.38) STSKMT2APDE4APDE4BPDE4C
SCHEMBL6349458 0.68 GABRA1 (0.40) PDE4APDE4BPDE4CPDE4DKDM1A
SCHEMBL26663735 0.67 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL26663249 0.67 PDE4B (0.45) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL17459681 0.66 PDE4B (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448933-A1 TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL](2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBOXYLIC ACID Eli Lilly and Company (US) 2012-05-09 EP disclosed
WO-2011002696-A1 TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL] (2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBOXYLIC ACID ELI LILLY AND COMPANY (US) 2011-01-06 WO disclosed